Timuçin, E. Et Al. 2019. Rationally designed FOXO4-p53 interfering peptide selectively kills chemo-therapy-induced senescent and dormant cancer cells in vivo. Ending Age-Related Diseases: Investment Prospects and Advances in Research conference , (New-York, United States Of America), 39.

Timuçin, E., Fischer, J. M., Sezerman, U., & Çınaroğlu, S. S., (2019). Rationally designed FOXO4-p53 interfering peptide selectively kills chemo-therapy-induced senescent and dormant cancer cells in vivo . Ending Age-Related Diseases: Investment Prospects and Advances in Research conference (pp.39). New-York, United States Of America

Timuçin, EMEL Et Al. "Rationally designed FOXO4-p53 interfering peptide selectively kills chemo-therapy-induced senescent and dormant cancer cells in vivo," Ending Age-Related Diseases: Investment Prospects and Advances in Research conference, New-York, United States Of America, 2019

Timuçin, EMEL Et Al. "Rationally designed FOXO4-p53 interfering peptide selectively kills chemo-therapy-induced senescent and dormant cancer cells in vivo." Ending Age-Related Diseases: Investment Prospects and Advances in Research conference , New-York, United States Of America, pp.39, 2019

Timuçin, E. Et Al. (2019) . "Rationally designed FOXO4-p53 interfering peptide selectively kills chemo-therapy-induced senescent and dormant cancer cells in vivo." Ending Age-Related Diseases: Investment Prospects and Advances in Research conference , New-York, United States Of America, p.39.

@conferencepaper{conferencepaper, author={EMEL TİMUÇİN Et Al. }, title={Rationally designed FOXO4-p53 interfering peptide selectively kills chemo-therapy-induced senescent and dormant cancer cells in vivo}, congress name={Ending Age-Related Diseases: Investment Prospects and Advances in Research conference}, city={New-York}, country={United States Of America}, year={2019}, pages={39} }